Actuate Therapeutics (ACTU): President, CEO and Director Schmitt Daniel M bought $50,000 worth of shares (140,844 units at $0.36) (SEC Form 4)
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for ACTU
Across the 15 sessions after earlier ACTU headlines, the stock closed higher 7 times and lower 8 times, with a median move of 8.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ACTU | SPY |
|---|---|---|---|
| Oct 27, 2026 | Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering | -24.3% | +0.6% |
| Sep 10, 2026 | Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference | -8.7% | -0.6% |
| Sep 9, 2026 | Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib | -8.0% | -0.5% |
| Jun 1, 2026 | Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer | -1.5% | +0.3% |
| May 11, 2026 | Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program | -9.8% | +0.2% |
| May 6, 2026 | Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors | -2.6% | +1.4% |
Earlier insider filings at ACTU
- Aug 14, 2026President, CEO and Director Schmitt Daniel M converted options into 272,056 shares and covered exercise/tax liability with 120,521 shares, increasing direct ownership by 101% to 301,716 units (SEC Form 4) (for withholding tax)
- May 22, 2026SEC Form 4 filed by Director Zabrowski Dan
- May 22, 2026SEC Form 4 filed by Director Thomson Todd S
- May 22, 2026SEC Form 4 filed by Director Sawhney Roger
- May 22, 2026SEC Form 4 filed by Director Ronneberg Amy L
Quantisnow market dataNASDAQ
ACTU
Actuate Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2024
Get push alerts for ACTU
Full ACTU profile on Quantisnow Follow ACTU and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time